Young Li
Stock Analyst at Jefferies
(0.28)
# 4,013
Out of 4,818 analysts
5
Total ratings
33.33%
Success rate
-25.75%
Average return
Main Sectors:
Stocks Rated by Young Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RXST RxSight | Initiates: Buy | $72 | $14.73 | +388.96% | 1 | Oct 29, 2024 | |
| COO The Cooper Companies | Upgrades: Buy | $107 → $115 | $82.58 | +39.26% | 1 | Jul 16, 2024 | |
| HYPR Hyperfine | Initiates: Hold | $1.25 | $0.77 | +61.64% | 1 | Nov 30, 2023 | |
| ENOV Enovis | Initiates: Buy | $60 | $35.09 | +70.99% | 1 | Oct 12, 2022 | |
| ANIK Anika Therapeutics | Initiates: Neutral | $46 | $14.41 | +219.22% | 1 | Jul 16, 2021 |
RxSight
Oct 29, 2024
Initiates: Buy
Price Target: $72
Current: $14.73
Upside: +388.96%
The Cooper Companies
Jul 16, 2024
Upgrades: Buy
Price Target: $107 → $115
Current: $82.58
Upside: +39.26%
Hyperfine
Nov 30, 2023
Initiates: Hold
Price Target: $1.25
Current: $0.77
Upside: +61.64%
Enovis
Oct 12, 2022
Initiates: Buy
Price Target: $60
Current: $35.09
Upside: +70.99%
Anika Therapeutics
Jul 16, 2021
Initiates: Neutral
Price Target: $46
Current: $14.41
Upside: +219.22%